Matinas Biopharma Holdings Other Current Assets

Matinas Biopharma Holdings (MTNB) currently reports a other current assets of $420K as of March 2026. That compares with $620K in the prior-year period — down 33.1% year over year. Use the charts on this page to explore Matinas Biopharma Holdings's other current assets history and peer comparisons.

Matinas Biopharma Holdings's other current assets decreased from $620K to $420K — a 33.1% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Matinas Biopharma Holdings reported $420K in other current assets as of March 2026. That compares with $620K in the prior-year period — down 33.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $420K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Matinas Biopharma Holdings, and consider following MTNB for alerts when major investors trade the stock.

Matinas Biopharma Holdings is classified in the Healthcare sector. On other current assets, it currently shows $420K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MTNB with unrelated industries.